BMAL1 and autoimmune disease: We demonstrate that mice with a targeted deletion of Bmal1 from myeloid cells have significantly enhanced pro-inflammatory and T cell-polarizing cytokine responses, resulting in heightened inflammation and enhanced susceptibility to the induction of autoimmune disease.